COGT
Price
$4.92
Change
-$0.07 (-1.41%)
Updated
May 9, 01:07 PM (EDT)
Capitalization
537.4M
95 days until earnings call
TVTX
Price
$20.49
Change
+$0.05 (+0.24%)
Updated
May 9, 02:51 PM (EDT)
Capitalization
1.82B
83 days until earnings call
Ad is loading...

COGT vs TVTX

Header iconCOGT vs TVTX Comparison
Open Charts COGT vs TVTXBanner chart's image
Cogent Biosciences
Price$4.92
Change-$0.07 (-1.41%)
Volume$1.5K
Capitalization537.4M
Travere Therapeutics
Price$20.49
Change+$0.05 (+0.24%)
Volume$700
Capitalization1.82B
COGT vs TVTX Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. TVTX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and TVTX is a Buy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (COGT: $4.98 vs. TVTX: $20.44)
Brand notoriety: COGT and TVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 78% vs. TVTX: 87%
Market capitalization -- COGT: $537.4M vs. TVTX: $1.82B
COGT [@Biotechnology] is valued at $537.4M. TVTX’s [@Biotechnology] market capitalization is $1.82B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileTVTX’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • TVTX’s FA Score: 0 green, 5 red.
According to our system of comparison, TVTX is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 4 TA indicator(s) are bullish while TVTX’s TA Score has 6 bullish TA indicator(s).

  • COGT’s TA Score: 4 bullish, 4 bearish.
  • TVTX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, TVTX is a better buy in the short-term than COGT.

Price Growth

COGT (@Biotechnology) experienced а -11.55% price change this week, while TVTX (@Biotechnology) price change was -1.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.62%. For the same industry, the average monthly price growth was +10.44%, and the average quarterly price growth was -13.61%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2025.

TVTX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-5.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TVTX($1.82B) has a higher market cap than COGT($537M). TVTX YTD gains are higher at: 17.336 vs. COGT (-36.154). TVTX (-265.77M) and COGT (-271.59M) have comparable annual earnings (EBITDA) . TVTX has more cash in the bank: 371M vs. COGT (287M). COGT has less debt than TVTX: COGT (17.5M) vs TVTX (402M). TVTX has higher revenues than COGT: TVTX (233M) vs COGT (0).
COGTTVTXCOGT / TVTX
Capitalization537M1.82B30%
EBITDA-271.59M-265.77M102%
Gain YTD-36.15417.336-209%
P/E RatioN/AN/A-
Revenue0233M-
Total Cash287M371M77%
Total Debt17.5M402M4%
FUNDAMENTALS RATINGS
COGT vs TVTX: Fundamental Ratings
COGT
TVTX
OUTLOOK RATING
1..100
2529
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
7481
SMR RATING
1..100
9697
PRICE GROWTH RATING
1..100
6536
P/E GROWTH RATING
1..100
10039
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COGT's Valuation (82) in the Miscellaneous industry is in the same range as TVTX (90) in the Biotechnology industry. This means that COGT’s stock grew similarly to TVTX’s over the last 12 months.

COGT's Profit vs Risk Rating (74) in the Miscellaneous industry is in the same range as TVTX (81) in the Biotechnology industry. This means that COGT’s stock grew similarly to TVTX’s over the last 12 months.

COGT's SMR Rating (96) in the Miscellaneous industry is in the same range as TVTX (97) in the Biotechnology industry. This means that COGT’s stock grew similarly to TVTX’s over the last 12 months.

TVTX's Price Growth Rating (36) in the Biotechnology industry is in the same range as COGT (65) in the Miscellaneous industry. This means that TVTX’s stock grew similarly to COGT’s over the last 12 months.

TVTX's P/E Growth Rating (39) in the Biotechnology industry is somewhat better than the same rating for COGT (100) in the Miscellaneous industry. This means that TVTX’s stock grew somewhat faster than COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTTVTX
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OISGX12.630.23
+1.85%
Optimum Small-Mid Cap Growth Instl
STCAX14.49N/A
N/A
Virtus Silvant Large-Cap Growth Stk I
BIGRX35.08N/A
N/A
American Century Discplnd Cor Val Inv
VTMSX83.06N/A
N/A
Vanguard Tax-Managed Small Cap Adm
HEMDX9.61-0.01
-0.10%
Janus Henderson Emerging Markets D